Doctor profile · Federal record
Dr. RAFAEL BEJAR, M.D., PH.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · Internal Medicine Physician · Hematology & Oncology Physician · LA JOLLA, CA
- NPI 1720051493
- Accepts Medicare
- 23 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3855 HEALTH SCIENCES DR, MC 0820
LA JOLLA, CA 920930820
(858) 534-5204
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- February 28, 2013
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- California #A121394 · Massachusetts #224210
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1720051493. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
98
Distinct HCPCS
4
Medicare allowed
$10,363
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 36 | 20 | $101 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 31 | 20 | $149 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 20 | 15 | $68 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 11 | 11 | $68 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 1,484. This provider delivers 0.1× the peer median.Open Payments
Industry payments received
All-time total
$7,600
Transactions
4
Manufacturers
2
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Gilead Sciences, Inc. | 2 | $4,000.00 | |
| Epizyme, Inc. | 2 | $3,600.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
78
Patients
0
Total drug cost
$712,524
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 39 | 0 | $36,471 |
| Revlimid (Lenalidomide) | Brand | 17 | 0 | $283,411 |
| Promacta (Eltrombopag Olamine) | Brand | 11 | 0 | $238,052 |
| Sprycel (Dasatinib) | Brand | 11 | 0 | $154,591 |